Cargando…

Current Management and Progress in Radiotherapy for Small Cell Lung Cancer

Radiotherapy (RT) and chemotherapy continue to be widely utilized in small cell lung cancer (SCLC) management. In most limited stage (LS)-SCLC cases, the standard initial therapy remains concurrent chemoradiotherapy (CRT), typically with an etoposide and platinum-based regimen. Hyperfractionated twi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tjong, Michael C., Mak, David Y., Shahi, Jeevin, Li, George J., Chen, Hanbo, Louie, Alexander V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372592/ https://www.ncbi.nlm.nih.gov/pubmed/32760673 http://dx.doi.org/10.3389/fonc.2020.01146

Ejemplares similares

Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer
por: Wujanto, Caryn, et al.
Publicado: (2019)

Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation
por: Chen, Hanbo, et al.
Publicado: (2018)

Stereotactic ablative radiotherapy for malignant mediastinal and hilar lymphadenopathy: a systematic review
por: Tjong, Michael C., et al.
Publicado: (2020)

A Review of Ongoing Trials of Stereotactic Ablative Radiotherapy for Oligometastatic Cancers: Where Will the Evidence Lead?
por: Al-Shafa, Faiez, et al.
Publicado: (2019)

Safety Related to the Timing of Radiotherapy and Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer: A Single Institutional Experience
por: Tjong, Michael C., et al.
Publicado: (2022)

Functional lung imaging in thoracic tumor radiotherapy: Application and progress
por: Zhou, Pi-Xiao, et al.
Publicado: (2022)

Role of Radiotherapy in Metastatic Non-Small Cell Lung Cancer
por: Faria, Sergio L.
Publicado: (2014)

Combining stereotactic body radiotherapy with immunotherapy in stage IV non-small cell lung cancer
por: Liu, Xiaoli, et al.
Publicado: (2023)

Feasibility of Tomotherapy-Based Image-Guided Radiotherapy for Small Cell Lung Cancer
por: Nguyen, Nam P., et al.
Publicado: (2013)

Is lung stereotactic ablative radiotherapy safe after pneumonectomy?—a systematic review
por: Arifin, Andrew J., et al.
Publicado: (2020)

Initial Clinical Experience of MR-Guided Radiotherapy for Non-Small Cell Lung Cancer
por: Crockett, Cathryn B., et al.
Publicado: (2021)

Progress in Radiotherapy for Cholangiocarcinoma
por: Wang, Ningyu, et al.
Publicado: (2022)

Comparison of Rapid to Standard Volumetric Modulated Arc Therapy for Palliative Radiotherapy in Lung Cancer Patients
por: Mak, David Y, et al.
Publicado: (2020)

The Utility of Positron Emission Tomography in the Treatment Planning of Image-Guided Radiotherapy for Non-Small Cell Lung Cancer
por: Chi, Alexander, et al.
Publicado: (2014)

Characterizing Surgical and Radiotherapy Outcomes in Non-metastatic High-Risk Prostate Cancer: A Systematic Review and Meta-Analysis
por: Guy, David E, et al.
Publicado: (2021)

Brain Radiation Necrosis: Current Management With a Focus on Non-small Cell Lung Cancer Patients
por: Loganadane, Gokoulakrichenane, et al.
Publicado: (2018)

Current treatments for non-small cell lung cancer
por: Guo, Qianqian, et al.
Publicado: (2022)

Expression of Concern: hTERT promoter methylation promotes small cell lung cancer progression and radiotherapy resistance
Publicado: (2021)

Stereotactic or Conventional Radiation for Early-Stage Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Mutsaers, Adam, et al.
Publicado: (2023)

Radiotherapy for Oligometastatic Lung Cancer
por: Bergsma, Derek P., et al.
Publicado: (2017)

Synchronous Oligometastatic Non-Small Cell Lung Cancer and Isolated Renal Cell Carcinoma: A Case Report and Literature Review
por: Nguyen, Timothy K, et al.
Publicado: (2015)

Radiotherapy Dosing for Locally Advanced Non-Small Cell Lung Carcinoma: “MTD” or “ALARA”?
por: Ohri, Nitin
Publicado: (2017)

The Value of Radiotherapy for Advanced Non-Small Cell Lung Cancer With Oncogene Driver-Mutation
por: Cui, Jinfeng, et al.
Publicado: (2022)

Machine learning in non-small cell lung cancer radiotherapy: A bibliometric analysis
por: Zhang, Jiaming, et al.
Publicado: (2023)

Dyspnea in Patients Receiving Radical Radiotherapy for Non-Small Cell Lung Cancer: A Prospective Study
por: Sardaro, Angela, et al.
Publicado: (2020)

Corrigendum: Machine learning in non-small cell lung cancer radiotherapy: a bibliometric analysis
por: Zhang, Jiaming, et al.
Publicado: (2023)

Is There a Role for Hypofractionated Thoracic Radiation Therapy in Limited-Stage Small Cell Lung Cancer? A Propensity Score Matched Analysis
por: Zayed, Sondos, et al.
Publicado: (2020)

Current status of and progress in the treatment of malignant pleural effusion of lung cancer
por: Zhao, Yuhua, et al.
Publicado: (2023)

Anlotinib combined with whole-brain radiotherapy in non-small cell lung cancer with multiple brain metastases that progressed or developed after at least one lines of prior treatment
por: Kong, Cheng, et al.
Publicado: (2023)

Predicting Outcomes From Radical Radiotherapy for Non-small Cell Lung Cancer: A Systematic Review of the Existing Literature
por: Walls, Gerard M., et al.
Publicado: (2018)

Modern Radiation Therapy for the Management of Brain Metastases From Non-Small Cell Lung Cancer: Current Approaches and Future Directions
por: Mantovani, Cristina, et al.
Publicado: (2021)

Stereotactic ablative radiotherapy for acquired resistance to EGFR therapy in metastatic non-small cell lung cancer
por: Chicas-Sett, Rodolfo, et al.
Publicado: (2023)

Propensity score-matched comparison of robotic- and video-assisted thoracoscopic surgery, and open lobectomy for non-small cell lung cancer patients aged 75 years or older
por: Pan, Hanbo, et al.
Publicado: (2022)

Update on the Biology, Management, and Treatment of Small Cell Lung Cancer (SCLC)
por: Saltos, Andreas, et al.
Publicado: (2020)

A combined predictive model based on radiomics features and clinical factors for disease progression in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy
por: Yang, Hong, et al.
Publicado: (2022)

The role of thoracic consolidative radiotherapy in the setting of immunotherapy in extensive stage small cell lung cancer
por: Verma, Saurav, et al.
Publicado: (2023)

MR-Guided Radiotherapy for Rectal Cancer: Current Perspective on Organ Preservation
por: Boldrini, Luca, et al.
Publicado: (2021)

Impact of Introducing Intensity Modulated Radiotherapy on Curative Intent Radiotherapy and Survival for Lung Cancer
por: Fornacon-Wood, Isabella, et al.
Publicado: (2022)

Research Progress on RET Fusion in Non-Small-Cell Lung Cancer
por: Zhao, Lu, et al.
Publicado: (2022)

Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer
por: Peng, Yurong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g83js0p7v12j89p68rbqu900bq